$21.28
▼ -0.1% Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
HR: Raising target price to $23.00
HR: What does Argus have to say about HR?
UBS Adjusts Price Target on Healthcare Realty Trust to $21 From $20, Maintains Neutral Rating
Overview
52-week range
$14
$21
100% of range
Avg surprise (last 2)
+1.2%
Avg reaction (last 1)
+2.3%
100% positive
Latest IV / EM
61%
EM ±13.9% · $23 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | — | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.17 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $0.41 | $0.40 | +2.5% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $0.39 | $0.39 | 0.0% | — | +2.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.26 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.39 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.82 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.18 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.22 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 30, 2026 | Jun/2026 | AMC | $0.40 | $0.41 | -2.4% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $279M | — | $298M | $298M | $299M | — | $315M | $316M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $-56,000 | — | $-58M | $-158M | $-45M | — | $-93M | $-144M |
| EPS (diluted) | — | — | $-0.17 | $-0.45 | $-0.13 | — | $-0.26 | $-0.39 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $26M | $26M | $43M | $26M | $26M | $69M | $23M | $42M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | — | — | — | — | — | — | — | — |
| Total assets | $9.15B | $9.21B | $9.86B | $10.24B | $10.50B | $10.65B | $11.24B | $11.80B |
| Long-term debt | $4.10B | $3.91B | $4.49B | $4.69B | $4.73B | $4.66B | $4.96B | $5.15B |
| Total liabilities | $4.65B | $4.53B | $5.11B | $5.35B | $5.35B | $5.35B | $5.65B | $5.83B |
| Total equity | $4.44B | $4.62B | $4.68B | $4.82B | $5.08B | $5.23B | $5.52B | $5.89B |